dpp4 and glp 1 GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? GLP-1-RA and DPP-4 inhibitors in
Description
The product information for all Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists (dulaglutide, exenatide, liraglutide, semaglutide and tirzepatide) has been further updated to highlight the potential risk of severe acute pancreatitis with these products, including rare reports of necrotising and fatal pancreatitis
What Are GLP-1 Medications
Recent evidence suggests these drugs also benefit heart, kidney, liver, and even brain health.
No worrieswere here to help
The GLP-1 gold rush is getting a lot less photogenic
